GBIO: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, GBIO has $121,896K in assets. $71,336K in debts. $21,940K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Cash and cash equivalents	21,940	49,094
Marketable securities	67,682	92,269
Collaboration receivable	391	256
Assets held for sale	1,070	-
Prepaid expenses and other current assets	2,379	3,883
Total current assets	93,462	145,502
Property and equipment, net	8,853	13,296
Operating lease right-of-use assets	17,429	18,415
Restricted cash	2,152	2,152
Other long-term assets	0	67
Total assets	121,896	179,432

Accounts payable	2,064	2,232
Accrued expenses and other current liabilities	12,475	5,872
Deferred revenue	149	1,514
Operating lease liabilities	6,352	9,752
Total current liabilities	21,040	19,370
Deferred revenue, net of current portion	30,552	30,389
Operating lease liabilities, net of current portion	19,744	75,572
Other liabilities, net of current portion	0	0
Total liabilities	71,336	125,331
Common stock, 0.0001 par value 150,000,000 shares authorized at september 30, 2025 and december 31, 2024 6,735,801 and 6,697,197 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively	1	1
Additional paid-in capital	794,841	792,866
Accumulated other comprehensive income	8	4
Accumulated deficit	-744,290	-738,770
Total stockholders' equity	50,560	54,101
Total liabilities and stockholders' equity	121,896	179,432